ObjectiveThe vocal biomarkers market was worth $1.9B in 2021 and is projected to exceed $5.1B by 2028, for a compound annual growth rate of 15.15%. The investment growth demonstrates a blossoming interest in voice and artificial intelligence (AI) as it relates to human health. The objective of this study was to map the current landscape of start‐ups utilizing voice as a biomarker in health‐tech.Data SourcesA comprehensive search for start‐ups was conducted using Google, LinkedIn, Twitter, and Facebook. A review of the research was performed using company website, PubMed, and Google Scholar.Review MethodsA 3‐pronged approach was taken to thoroughly map the landscape. First, an internet search was conducted to identify current start‐ups focusing on products relating to voice as a biomarker of health. Second, Crunchbase was utilized to collect financial and organizational information. Third, a review of the literature was conducted to analyze publications associated with the identified start‐ups.ResultsA total of 27 start‐up start‐ups with a focus in the utilization of AI for developing biomarkers of health from the human voice were identified. Twenty‐four of these start‐ups garnered $178,808,039 in investments. The 27 start‐ups published 194 publications combined, 128 (66%) of which were peer reviewed.ConclusionThere is growing enthusiasm surrounding voice as a biomarker in health‐tech. Academic drive may complement commercialization to best achieve progress in this arena. More research is needed to accurately capture the entirety of the field, including larger industry players, academic institutions, and non‐English content.